Antimicrobial use and drug–drug interactions among nursing home residents in Singapore: a multicentre prevalence study
- 124 Downloads
Background With the Ministry of Health’s projected increase in nursing home beds and optimization of antimicrobial use in health care settings, it is therefore timely to consider baseline prevalence and patterns of antimicrobial use at nursing homes in Singapore as well as to evaluate the prevalence of potential clinically significant drug–drug interactions involving antimicrobials. Objective The primary objective was to determine the prevalence and patterns of antimicrobial use at nursing homes in Singapore. The secondary objective was to evaluate the prevalence of potential clinically significant drug–drug interactions involving antimicrobials. Setting Four nursing homes in Singapore. Method A retrospective cross-sectional study was conducted among nursing home residents. The antimicrobial prevalence, defined daily doses, days of therapy, and potential drug–drug interactions were determined using data from archived resident medication prescribing and administration records. Main outcome measure Prevalence and patterns of antimicrobial use, drug–drug interactions involving antimicrobials. Results Among 707 residents (mean age: 80.7 ± 8.8 years, female: 57.1%), 10% used antimicrobials during the study month, with a 1-day point prevalence of 3%. The utilization rates of antimicrobials were 28.9 defined daily doses/1000 resident-days and 24.8 days of therapy/1000 resident-days. Potential drug–drug interactions involving antimicrobials were identified among 32 of the 70 (46%) residents who were prescribed antimicrobials. Of these, 26 (81%) residents had 43 potential clinically significant drug–drug interactions. Conclusions The prevalence and utilization rates of antimicrobial use in Singapore nursing homes appear to be low. Yet, potential clinically significant drug–drug interactions are prevalent.
KeywordsAntimicrobial use Drug interactions Elderly Nursing home Prevalence Singapore
This study did not receive any external funding.
Conflicts of interest
The authors declare no conflict of interest.
- 1.Centers for Disease Control and Prevention. The core elements of antibiotic stewardship. https://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html. Accessed 30 Jan 2018.
- 6.Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.CrossRefGoogle Scholar
- 7.Improving the intermediate and long-term care sector for the benefit of patients. http://getforme.com/. Accessed 30 Jan 2018.
- 9.Ministry of Health Singapore Launch of National Strategic Action Plan on Antimicrobial Resistance. https://www.moh.gov.sg/content/moh_web/home/pressRoom/pressRoomItemRelease/2017/launch-ofnational-strategic-action-plan-on-antimicrobial-resist.html. Accessed 30 Jan 2018.
- 17.Ministry of Health Singapore Residents Assessment Form. https://elis.moh.gov.sg/elis/publishInfo.do?task=download&pkId=167. Accessed 30 Jan 2018.
- 18.World Health Organization Anatomic Therapeutic Code & Defined Daily Dose Index. https://www.whocc.no/atc_ddd_index/. Accessed 30 Jan 2018.
- 20.Lexicomp Drug Interaction Checker for UpToDate. http://www.uptodate.com.libproxy1.nus.edu.sg/crlsql/inter-act/frameset.jsp. Accessed 30 Jan 2018.